Lopresti L, Tatangelo V, Baldari C, Patrussi L
Front Immunol. 2024; 15:1418527.
PMID: 39281678
PMC: 11392891.
DOI: 10.3389/fimmu.2024.1418527.
Hehar N, Chigbu D
Life (Basel). 2024; 14(3).
PMID: 38541686
PMC: 10971875.
DOI: 10.3390/life14030361.
Chigbu D, Karbach N, Abu S, Hehar N
Life (Basel). 2024; 14(3).
PMID: 38541674
PMC: 10971254.
DOI: 10.3390/life14030350.
Ghanbari Naeini L, Abbasi L, Karimi F, Kokabian P, Abdi Abyaneh F, Naderi D
J Immunol Res. 2023; 2023:7097329.
PMID: 37649897
PMC: 10465260.
DOI: 10.1155/2023/7097329.
Chakraborty S, Schneider J, Mitra D, Kubatzky K
Immunology. 2023; 169(3):309-322.
PMID: 36732282
PMC: 7615986.
DOI: 10.1111/imm.13630.
Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system.
Wong J, Ma J, Jobling A, Brandli A, Greferath U, Fletcher E
Front Neurosci. 2022; 16:1009599.
PMID: 36408381
PMC: 9670140.
DOI: 10.3389/fnins.2022.1009599.
IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer.
Heim L, Yang Z, Tausche P, Hohenberger K, Chiriac M, Koelle J
Front Immunol. 2022; 13:859738.
PMID: 35514957
PMC: 9065342.
DOI: 10.3389/fimmu.2022.859738.
JAK inhibitors and COVID-19.
Levy G, Guglielmelli P, Langmuir P, Constantinescu S
J Immunother Cancer. 2022; 10(4).
PMID: 35459733
PMC: 9035837.
DOI: 10.1136/jitc-2021-002838.
Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.
Patrussi L, Capitani N, Baldari C
Cancers (Basel). 2021; 13(24).
PMID: 34944921
PMC: 8699356.
DOI: 10.3390/cancers13246301.
Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation.
Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y
Microorganisms. 2021; 9(7).
PMID: 34202088
PMC: 8304202.
DOI: 10.3390/microorganisms9071381.
Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to .
Bamorovat M, Sharifi I, Oliaee R, Jafarzadeh A, Khosravi A
Front Microbiol. 2021; 12:638957.
PMID: 34140933
PMC: 8203913.
DOI: 10.3389/fmicb.2021.638957.
Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype.
Gonzalez Acera M, Patankar J, Diemand L, Siegmund B, Neurath M, Wirtz S
Front Med (Lausanne). 2021; 8:664045.
PMID: 34136502
PMC: 8200538.
DOI: 10.3389/fmed.2021.664045.
T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.
Wang W, Sung N, Gilman-Sachs A, Kwak-Kim J
Front Immunol. 2020; 11:2025.
PMID: 32973809
PMC: 7461801.
DOI: 10.3389/fimmu.2020.02025.
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain.
Donninelli G, Saraf-Sinik I, Mazziotti V, Capone A, Grasso M, Battistini L
J Neuroinflammation. 2020; 17(1):149.
PMID: 32375811
PMC: 7204302.
DOI: 10.1186/s12974-020-01770-z.
Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role.
Allegra A, Musolino C, Tonacci A, Pioggia G, Casciaro M, Gangemi S
Cancers (Basel). 2020; 12(2).
PMID: 32102441
PMC: 7072434.
DOI: 10.3390/cancers12020524.
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.
Dayakar A, Chandrasekaran S, Kuchipudi S, Kalangi S
Front Immunol. 2019; 10:670.
PMID: 31024534
PMC: 6459942.
DOI: 10.3389/fimmu.2019.00670.
Minimum degree of overlap between IL-9R and IL-2R on human T lymphoma cells: A quantitative CLSM and FRET analysis.
Nizsaloczki E, Nagy P, Mocsar G, Szabo A, Csomos I, Waldmann T
Cytometry A. 2018; 93(11):1106-1117.
PMID: 30378727
PMC: 8108070.
DOI: 10.1002/cyto.a.23634.
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice.
Macri S, Spinello C, Widomska J, Magliozzi R, Poelmans G, Invernizzi R
Sci Rep. 2018; 8(1):10188.
PMID: 29976948
PMC: 6033871.
DOI: 10.1038/s41598-018-28372-3.
Evaluation of Interleukin-9 Expression as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in a Cohort of Egyptian Patients.
Abbassy H, Aboelwafa R, Ghallab O
Indian J Hematol Blood Transfus. 2017; 33(4):477-482.
PMID: 29075057
PMC: 5640552.
DOI: 10.1007/s12288-017-0804-1.
Association between low expression levels of interleukin-9 and colon cancer progression.
Huang Y, Cao Y, Zhang S, Gao F
Exp Ther Med. 2015; 10(3):942-946.
PMID: 26622419
PMC: 4533221.
DOI: 10.3892/etm.2015.2588.